245 related articles for article (PubMed ID: 34877074)
21. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
22. The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma.
Thom JJ; Moore EJ; Price DL; Kasperbauer JL; Starkman SJ; Olsen KD
JAMA Otolaryngol Head Neck Surg; 2014 Jun; 140(6):548-54. PubMed ID: 24722863
[TBL] [Abstract][Full Text] [Related]
23. Stage IV cutaneous squamous cell carcinoma: treatment outcomes in a series of 42 patients.
Chapalain M; Baroudjian B; Dupont A; Lhote R; Lambert J; Bagot M; Lebbe C; Basset-Seguin N
J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1202-1209. PubMed ID: 31587382
[TBL] [Abstract][Full Text] [Related]
24. A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis.
Cañueto J; Tejera-Vaquerizo A; Redondo P; Botella-Estrada R; Puig S; Sanmartin O
Actas Dermosifiliogr (Engl Ed); 2020 May; 111(4):281-290. PubMed ID: 32359704
[TBL] [Abstract][Full Text] [Related]
25. Update on Management Recommendations for Advanced Cutaneous Squamous Cell Carcinoma.
García-Foncillas J; Tejera-Vaquerizo A; Sanmartín O; Rojo F; Mestre J; Martín S; Azinovic I; Mesía R
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158897
[TBL] [Abstract][Full Text] [Related]
26. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
27. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
[TBL] [Abstract][Full Text] [Related]
28. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
[TBL] [Abstract][Full Text] [Related]
29. The Value of Adjuvant Radiotherapy in Cutaneous Squamous Cell Carcinoma: A Review.
Cañueto J; Jaka A; Toll A
Actas Dermosifiliogr (Engl Ed); 2018; 109(6):476-484. PubMed ID: 29759308
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of invasive cutaneous squamous cell carcinoma, imaging and staging.
Dessinioti C; Liopyris K; Stratigos AJ
Ital J Dermatol Venerol; 2024 Apr; 159(2):118-127. PubMed ID: 38650493
[TBL] [Abstract][Full Text] [Related]
31. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease.
Veness MJ; Palme CE; Morgan GJ
Cancer; 2006 Jun; 106(11):2389-96. PubMed ID: 16649220
[TBL] [Abstract][Full Text] [Related]
32. The Roles of lncRNA in Cutaneous Squamous Cell Carcinoma.
Wang Y; Sun B; Wen X; Hao D; Du D; He G; Jiang X
Front Oncol; 2020; 10():158. PubMed ID: 32185124
[TBL] [Abstract][Full Text] [Related]
33. A case of head and neck cutaneous squamous cell carcinoma highlighting aggressive perineural features.
Kalil GH; Taylor CS; Jefferson GD
Radiol Case Rep; 2022 Dec; 17(12):4459-4461. PubMed ID: 36189160
[TBL] [Abstract][Full Text] [Related]
34. Guidelines of care for the management of cutaneous squamous cell carcinoma.
; ; Kim JYS; Kozlow JH; Mittal B; Moyer J; Olenecki T; Rodgers P
J Am Acad Dermatol; 2018 Mar; 78(3):560-578. PubMed ID: 29331386
[TBL] [Abstract][Full Text] [Related]
35. New and emerging drugs for the treatment of advanced cutaneous squamous cell carcinoma.
Bonini F; de Sousa LG; Ferrarotto R
Expert Opin Emerg Drugs; 2023 Dec; 28(2):97-106. PubMed ID: 37144289
[TBL] [Abstract][Full Text] [Related]
36. Update of advanced cutaneous squamous cell carcinoma.
de Jong E; Lammerts MUPA; Genders RE; Bouwes Bavinck JN
J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1(Suppl 1):6-10. PubMed ID: 34855246
[TBL] [Abstract][Full Text] [Related]
37. Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review.
Farberg AS; Fitzgerald AL; Ibrahim SF; Tolkachjov SN; Soleymani T; Douglas LM; Kurley SJ; Arron ST
Dermatol Ther (Heidelb); 2022 Feb; 12(2):267-284. PubMed ID: 34994967
[TBL] [Abstract][Full Text] [Related]
38. High-risk cutaneous squamous cell carcinoma (CSCC): Challenges and emerging therapies.
Halim AS; Ramasenderan N
Asian J Surg; 2023 Jan; 46(1):47-51. PubMed ID: 35545474
[TBL] [Abstract][Full Text] [Related]
39. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors Party Together: The Role of Perineural Invasion and Desmoplasia in Cutaneous Squamous Cell Carcinoma Prognosis.
Jambusaria-Pahlajani A; Karia PS; Schmults CD
J Invest Dermatol; 2020 Oct; 140(10):1893-1894. PubMed ID: 32972522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]